Search research articles
Contact Us
Filters
Showing results (271-280 of 286) with videos related to
Page
of 29
Sort By:
Gastroenterology
|
May 6, 2018
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study
Charlotte E Costentin, Richard Layese, Valérie Bourcier, et al.
Hepatology (Baltimore, Md.)
|
April 18, 2018
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication
Manon Allaire, Pierre Nahon, Richard Layese, et al.
Nature Communications
|
February 10, 2023
Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis
Josepmaria Argemi, Maria U Latasa, Stephen R Atkinson, et al.
Journal of Hepatology
|
October 17, 2021
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers
John B Whitfield, Tae-Hwi Schwantes-An, Rebecca Darlay, et al.
Journal of Hepatology
|
March 15, 2022
Corrigendum to: 'A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers' [J Hepatol 2022 (76) 275-282]
John B Whitfield, Tae-Hwi Schwantes-An, Rebecca Darlay, et al.
Gastroenterology
|
February 16, 2019
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy
Dominique Thabut, Christophe Bureau, Richard Layese, et al.
Gut
|
October 30, 2015
Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)
Pierre Nahon, Mathilde Lescat, Richard Layese, et al.
Gastroenterology
|
September 20, 2016
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon, Valérie Bourcier, Richard Layese, et al.
Journal of Hepatology
|
November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program
Christiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
Hepatology Communications
|
May 10, 2024
A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry
Tae-Hwi Schwantes-An, John B Whitfield, Guruprasad P Aithal, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 286) with videos related to
Sort By:
Page
of 29
Gastroenterology
|
May 6, 2018
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study
Charlotte E Costentin, Richard Layese, Valérie Bourcier, et al.
Hepatology (Baltimore, Md.)
|
April 18, 2018
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication
Manon Allaire, Pierre Nahon, Richard Layese, et al.
Nature Communications
|
February 10, 2023
Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis
Josepmaria Argemi, Maria U Latasa, Stephen R Atkinson, et al.
Journal of Hepatology
|
October 17, 2021
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers
John B Whitfield, Tae-Hwi Schwantes-An, Rebecca Darlay, et al.
Journal of Hepatology
|
March 15, 2022
Corrigendum to: 'A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers' [J Hepatol 2022 (76) 275-282]
John B Whitfield, Tae-Hwi Schwantes-An, Rebecca Darlay, et al.
Gastroenterology
|
February 16, 2019
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy
Dominique Thabut, Christophe Bureau, Richard Layese, et al.
Gut
|
October 30, 2015
Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)
Pierre Nahon, Mathilde Lescat, Richard Layese, et al.
Gastroenterology
|
September 20, 2016
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon, Valérie Bourcier, Richard Layese, et al.
Journal of Hepatology
|
November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program
Christiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
Hepatology Communications
|
May 10, 2024
A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry
Tae-Hwi Schwantes-An, John B Whitfield, Guruprasad P Aithal, et al.
Page
of 29